Skip to main content
Log in

The Vasoactive Peptide Angiotensin-(1–7), Its Receptor Mas and the Angiotensin-converting Enzyme Type 2 are Expressed in the Human Endometrium

  • Published:
Reproductive Sciences Aims and scope Submit manuscript

Abstract

Angiotensin (Ang)-(1–7) is one of the major active components of the renin-angiotensin system, produced from cleavage of Ang II by angiotensin-converting-enzyme type 2 (ACE2), which acts through a specific G protein-coupled receptor, Mas. We have investigated whether the human endometrium expresses these components during menstrual cycle. By radioimmunoassay, Ang-(1–7) was detected in endometrial wash fluid at picomolar concentrations. Using immunofluorescence, both the peptide and its receptor were identified in cultured endometrial epithelial and stromal cells. By immunohistochemistry, Ang(1–7) was localized in the endometrium throughout menstrual cycle, being more concentrated in the glandular epithelium of mid- and late secretory phase. This pattern corresponded to the ACE2 mRNA, which was more abundant in epithelial cells than in stromal cells (2-fold increase, p < 0.05) and in the secretory vs. proliferative phase (6.6-fold increase, p < 0.01). The receptor Mas was equally distributed between epithelial and stromal cells and did not change during menstrual cycle. The physiological role of this peptide system in normal and pathological endometrium warrants further investigation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Campbell DJ. Circulating and tissue angiotensin systems. J Clin Invest. 1987;79:1–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Reudelhuber TL. A place in our hearts for the lowly angiotensin 1–7 peptide? Hypertension. 2006;47:811–815.

    Article  CAS  PubMed  Google Scholar 

  3. Peach MJ. Renin-angiotensin system: biochemistry and mechanisms of action. Physiol Rev. 1977;57:313–370.

    Article  CAS  PubMed  Google Scholar 

  4. Nakashima H, Suzuki H, Ohtsu H, et al. Angiotensin II regulates vascular and endothelial dysfunction: recent topics of Angiotensin II type-1 receptor signaling in the vasculature. Curr Vasc Pharmacol. 2006;4:67–78.

    Article  CAS  PubMed  Google Scholar 

  5. Le Noble FA, Schreurs NH, van Straaten HW, et al. Evidence for a novel angiotensin II receptor involved in angiogenesis in chick embryo chorioallantoic membrane. Am J Physiol. 1993;264:R460-R465.

    PubMed  Google Scholar 

  6. Fernandez LA, Twickler J, Mead A. Neovascularization produced by angiotensin II. J Lab Clin Med. 1985;105:141–145.

    CAS  PubMed  Google Scholar 

  7. Yamada T, Horiuchi M, Dzau VJ. Angiotensin II type 2 receptor mediates programmed cell death. Proc Natl Acad Sci USA. 1996;93:156–160.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Goldenberg I, Grossman E, Jacobson KA, Shneyvays V, Shainberg A. Angiotensin II-induced apoptosis in rat cardiomyocyte culture: a possible role of AT1 and AT2 receptors. J Hypertens. 2001;19:1681–1689.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Ferris TF, Gorden P, Mulrow PJ. Rabbit uterus as a source of renin. Am J Physiol. 1967;212:698–702.

    Article  CAS  PubMed  Google Scholar 

  10. Shaw KJ, Do YS, Kjos S, et al. Human decidua is a major source of renin. J Clin Invest. 1989;83:2085–2092.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Shah DM, Higuchi K, Inagami T, Osteen KG. Effect of progesterone on renin secretion in endometrial stromal, chorionic trophoblast, and mesenchymal monolayer cultures. Am J Obstet Gynecol. 1991;164:1145–1150.

    Article  CAS  PubMed  Google Scholar 

  12. Ahmed A, Li XF, Shams M, et al. Localization of the angiotensin II and its receptor subtype in human endometrium and identification of a novel high-affinity angiotensin II binding site. J Clin Invest. 1995;96:848–857.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Saridogan E, Dahanbakhch O, Puddefoot JR, et al. Type1 angiotensin II receptor in human endometrium. Human Reprod. 1996;2:659–664.

    Article  CAS  Google Scholar 

  14. Li XF, Ahmed A. Compartmentalization and cyclic variation of immunoreactivity of renin and angiotensin converting enzyme in human endometrium throughout the menstrual cycle. Hum Reprod. 1997;12:2804–2809.

    Article  CAS  PubMed  Google Scholar 

  15. Li XF, Ahmed A. Expression of angiotensin II and its receptor subtypes in endometrial hyperplasia: a possible role in dysfunctional menstruation. Lab Invest. 1996;75:137–145.

    CAS  PubMed  Google Scholar 

  16. Ferrario CM, Chappell MC, Tallant EA, Brosnihan KB, Diz DI. Counter-regulatory actions of angiotensin-(1–7). Hypertension. 1997;30:535–541.

    Article  CAS  PubMed  Google Scholar 

  17. Santos RA, Ferreira AJ, Simões e Silva AC. Recent advances in the angiotensin-converting enzyme 2-angiotensin(1–7)-Mas axis. Exp Physiol. 2008;93:519–527.

    Article  CAS  PubMed  Google Scholar 

  18. Donoghue M, Hsieh F, Baronas E, et al. A novel angiotensin-convertingenzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1–9. Circ Res. 2000;87:E1–E9.

    Article  CAS  PubMed  Google Scholar 

  19. Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, Turner AJ. A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem. 2000;275:33238–33243.

    Article  CAS  PubMed  Google Scholar 

  20. Santos RAS, Simoes e Silva AC, Maric C, et al. Angiotensin(1–7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci USA. 2003;100:8258–8263.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Freeman EJ, Chisolm GM, Ferrario CM, Tallant EA. Angiotensin-(1–7) inhibits vascular smooth muscle cell growth. Hypertension. 1996;28:104–108.

    Article  CAS  PubMed  Google Scholar 

  22. Tallant EA, Diz DI, Ferrario CM. State-of-the-Art lecture. Antiproliferative actions of angiotensin-(1–7) in vascular smooth muscle. Hypertension. 1999;34:950–957.

    Article  CAS  PubMed  Google Scholar 

  23. Strawn WB, Ferrario CM, Tallant EA. Angiotensin-(1–7) reduces smooth muscle growth after vascular injury. Hypertension. 1999;33:207–211.

    Article  CAS  PubMed  Google Scholar 

  24. Tallant EA, Clark MA. Molecular mechanisms of inhibition of vascular growth by angiotensin-(1–7). Hypertension. 2003;42: 574–579.

    Article  CAS  PubMed  Google Scholar 

  25. Anton L, Merrill DC, Neves LA, Brosnihan KB. Angiotensin-(1–7) inhibits in vitro endothelial cell tube formation in human umbilical vein endothelial cells through the AT(1–7) receptor. Endocrine. 2007;32:212–218.

    Article  CAS  PubMed  Google Scholar 

  26. Sampaio WO, Henrique de Castro C, Santos RA, Schiffrin EL, Touyz RM. Angiotensin-(1–7) counterregulates angiotensin II signaling in human endothelial cells. Hypertension. 2007;50:1093–1098.

    Article  CAS  PubMed  Google Scholar 

  27. Sampaio WO, Santos RA, Faria-Silva R, da Mata Machado LT, Schiffrin EL, Touyz RM. Angiotensin-(1–7) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways. Hypertension. 2007;49:185–192.

    Article  CAS  PubMed  Google Scholar 

  28. Simoes e Silva AC, Diniz JS, Regueira-Filho A, Santos RA. The renin angiotensin system in childhood hypertension: selective increase of angiotensin-(1–7) in essential hypertension. J Pediatr. 2004;145:93–98.

    Article  CAS  PubMed  Google Scholar 

  29. Botelho LM, Block CH, Khosla MC, Santos RA. Plasma angiotensin(1–7) immunoreactivity is increased by salt load, water deprivation, and hemorrhage. Peptides. 1994;15: 723–729.

    Article  CAS  PubMed  Google Scholar 

  30. da Costa Gonçalves AC, Leite R, Fraga-Silva RA, et al. Evidence that the vasodilator angiotensin-(1–7)-Mas axis plays an important role in erectile function. Am J Physiol Heart Circ Physiol. 2007;293:H2588-H2596.

    Article  PubMed  CAS  Google Scholar 

  31. Becker LK, Etelvino GM, Walther T, Santos RA, Campagnole-Santos MJ. Immunofluorescence localization of the receptor Mas in cardiovascular-related areas of the rat brain. Am J Physiol Heart Circ Physiol. 2007;293:H1416-H1424.

    Article  CAS  PubMed  Google Scholar 

  32. Lucidi RS, Witz CA, Chrisco M, Binkley PA, Shain SA, Schenken RS. A novel in vitro model of the early endometriotic lesion demonstrates that attachment of endometrial cells to mesothelial cells is dependent on the source of endometrial cells. Fertil Steril. 2005;84:16–21.

    Article  PubMed  Google Scholar 

  33. Catalano RD, Critchley HO, Heikinheimo O, et al. Mifepristone induced progesterone withdrawal reveals novel regulatory pathways in human endometrium. Mol Hum Reprod. 2007;13:641–654.

    Article  CAS  PubMed  Google Scholar 

  34. Li XF, Ahmed A. Dual role of angiotensin II in the human endometrium. Hum Reprod. 1996;11:95–108.

    Article  CAS  PubMed  Google Scholar 

  35. Neves LA, Stovall K, Joyner J, et al. ACE2 and ANG-(1–7) in the rat uterus during early and late gestation. Am J Physiol Regul Integr Comp Physiol. 2008;294:R151–R161.

    Article  CAS  PubMed  Google Scholar 

  36. Vickers C, Hales P, Kaushik V. Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J Biol Chem. 2002;277:14838–14843.

    Article  CAS  PubMed  Google Scholar 

  37. Paizis G, Tikellis C, Cooper ME, et al. Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2. Gut. 2005;54:1790–1796.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Kostenis E, Milligan G, Christopoulos A, et al. G-protein-coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor. Circulation. 2005;111:1806–1813.

    Article  CAS  PubMed  Google Scholar 

  39. Simões e Silva AC, Pinheiro SV, Pereira RM, Ferreira AJ, Santos RA. The therapeutic potential of Angiotensin-(1–7) as a novel Renin-Angiotensin System mediator. Mini Rev Med Chem. 2006;6:603–609.

    Article  CAS  PubMed  Google Scholar 

  40. Daemen MJ, Lombardi DM, Bosman FT, Schwartz SM. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res. 1991;68:450–456.

    Article  CAS  PubMed  Google Scholar 

  41. Sugawara A, Ito S. Stimulatory effects of angiotensin II on angiogenesis. Nippon Rinsho. 2006;64(suppl 5):67–69.

    PubMed  Google Scholar 

  42. Bonnet F, Cao Z, Cooper ME. Apoptosis and angiotensin II: yet another renal regulatory system? Exp Nephrol. 2001;9:295–300.

    Article  CAS  PubMed  Google Scholar 

  43. Benter IF, Diz DI, Ferrario CM. Cardiovascular actions of angiotensin-(1–7). Peptides. 1993;14:679–684.

    Article  CAS  PubMed  Google Scholar 

  44. Li P, Chappell MC, Ferrario CM, Brosnihan KB. Angiotensin-(1–7) augments bradykinin-induced vasodilation by competing with ACE and releasing nitric oxide. Hypertension. 1997;29:394–400.

    Article  CAS  PubMed  Google Scholar 

  45. Machado RDP, Santos RAS, Andrade SP. Opposing actions of angiotensins on angiogenesis. Life Sci. 1999;66:67–76.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to F. M. Reis MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vaz-Silva, J., Carneiro, M.M., Ferreira, M.C. et al. The Vasoactive Peptide Angiotensin-(1–7), Its Receptor Mas and the Angiotensin-converting Enzyme Type 2 are Expressed in the Human Endometrium. Reprod. Sci. 16, 247–256 (2009). https://doi.org/10.1177/1933719108327593

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1177/1933719108327593

Key words

Navigation